The premenopausal and menopausal phases are biological processes in women with a decline in estrogen and contribute to the changes of increased abdominal fat deposition. The clinical implications to global cardiometabolic risk have been extensively reviewed but few studies have reported the relationship between different bedside anthropometric obesity indices and subclinical vascular disease, an early marker of cardiac atherosclerosis.